Disruption of Cav1.2-mediated signaling is a pathway for ketamine-induced pathology
Ketamine is a general anesthetic that is used also as an anti-depressant, but its use is associated with cystitis. Here, the authors show that ketamine is an antagonist of the Cav1.2 channel in bladder smooth muscle cells, that ablation of this channel in mice mimics the cystitis induced by ketamine...
Guardado en:
Autores principales: | Huan Chen, David H. Vandorpe, Xiang Xie, Seth L. Alper, Mark L. Zeidel, Weiqun Yu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4c6049dad79c426db90368daaeea5f52 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Allicin disrupts cardiac Cav1.2 channels via trafficking
por: Dan Han, et al.
Publicado: (2019) -
The interactive effects of ketamine and magnesium upon depressive-like pathology
por: Razmjou S, et al.
Publicado: (2016) -
Function of cone and cone-related pathways in CaV1.4 IT mice
por: Lucia Zanetti, et al.
Publicado: (2021) -
Endocannabinoid signaling regulates the reinforcing and psychostimulant effects of ketamine in mice
por: Wei Xu, et al.
Publicado: (2020) -
Identification of Molecular Markers of Clozapine Action in Ketamine-Induced Cognitive Impairment: A GPCR Signaling PathwayFinder Study
por: Agata Korlatowicz, et al.
Publicado: (2021)